title: Oral administration of methylphenidate blocks the effect of cocaine on uptake at the Drosophila dopamine transporter.
abstract: Although our understanding of the actions of cocaine in the brain has improved, an effective drug treatment for cocaine addiction has yet to be found. Methylphenidate binds the dopamine transporter and increases extracellular dopamine levels in mammalian central nervous systems similar to cocaine, but it is thought to elicit fewer addictive and reinforcing effects owing to slower pharmacokinetics for different routes of administration between the drugs. This study utilizes the fruit fly model system to quantify the effects of oral methylphenidate on dopamine uptake during direct cocaine exposure to the fly CNS. The effect of methylphenidate on the dopamine transporter has been explored by measuring the uptake of exogenously applied dopamine. The data suggest that oral consumption of methylphenidate inhibits the Drosophila dopamine transporter and the inhibition is concentration dependent. The peak height increased to 150% of control when cocaine was used to block the dopamine transporter for untreated flies but only to 110% for methylphenidate-treated flies. Thus, the dopamine transporter is mostly inhibited for the methylphenidate-fed flies before the addition of cocaine. The same is true for the rate of the clearance of dopamine measured by amperometry. For untreated flies the rate of clearance changes 40% when the dopamine transporter is inhibited with cocaine, and for treated flies the rate changes only 10%. The results were correlated to the in vivo concentration of methylphenidate determined by CE-MS. Our data suggest that oral consumption of methylphenidate inhibits the Drosophila dopamine transporter for cocaine uptake, and the inhibition is concentration dependent.
authors: Department of Chemistry and Molecular Biology, University of Gothenburg, Kemivägen 10, SE-412 96, Göteborg, Sweden.
authors: E Carina
authors: EC
authors: Berglund
authors: Monique A
authors: MA
authors: Makos
authors: Jacqueline D
authors: JD
authors: Keighron
authors: Nhu
authors: N
authors: Phan
authors: Michael L
authors: ML
authors: Heien
authors: Andrew G
authors: AG
authors: Ewing
mesh_terms: D000284:Administration, Oral; D000818:Animals; D030801:Animals, Genetically Modified; D003042:Cocaine / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004331:Drosophila melanogaster; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage*
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; D008774:Methylphenidate; D003042:Cocaine
references: J Exp Biol. 2009 Jan;212(Pt 2):163-8
references: 19112134
references: Drugs. 2004;64(14):1547-73
references: 15233592
references: J Physiol. 1955 Sep 28;129(3):568-82
references: 13264118
references: Trends Pharmacol Sci. 2003 Jan;24(1):41-3
references: 12498730
references: J Clin Psychopharmacol. 1997 Dec;17(6):485-8
references: 9408812
references: J Neurosci. 2002 Aug 15;22(16):7264-71
references: 12177221
references: Int J Neuropsychopharmacol. 2008 May;11(3):425-38
references: 17927843
references: J Neurosci Methods. 2002 Nov 15;121(1):41-52
references: 12393160
references: Addict Biol. 2014 Mar;19(2):145-55
references: 22458761
references: Pharmacol Biochem Behav. 2006 Sep;85(1):29-38
references: 16916538
references: Anal Chem. 2009 Nov 15;81(22):9306-13
references: 19842636
references: Cell. 2003 Jan 24;112(2):271-82
references: 12553914
references: ACS Chem Neurosci. 2011 Dec 21;2(12):723-729
references: 22308204
references: Curr Biol. 2000 Feb 24;10(4):187-94
references: 10704411
references: Mol Pharmacol. 2001 Jan;59(1):83-95
references: 11125028
references: J Neurochem. 1992 Jul;59(1):259-66
references: 1613502
references: Curr Biol. 1998 Jan 15;8(2):109-12
references: 9427649
references: Brain Res. 1986 May 14;373(1-2):85-91
references: 3487373
references: Mol Cell Biochem. 2007 Apr;298(1-2):41-8
references: 17131045
references: J Clin Psychopharmacol. 2000 Feb;20(1):61-8
references: 10653210
references: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
references: 2899326
references: JAMA. 1965 Aug 23;193:646-50
references: 14321530
references: J Neurosci. 2005 Aug 10;25(32):7377-84
references: 16093388
references: Life Sci. 1999;65(1):PL7-12
references: 10403500
references: Neuropsychopharmacology. 2012 Jun;37(7):1708-16
references: 22395730
references: Nature. 1996 Feb 15;379(6566):606-12
references: 8628395
references: J Pharmacol Exp Ther. 1989 Oct;251(1):150-5
references: 2529365
references: J Exp Anal Behav. 1973 Jul;20(1):119-29
references: 4197505
references: Analyst. 2003 Dec;128(12):1413-9
references: 14737224
references: Am J Psychiatry. 1998 Oct;155(10):1325-31
references: 9766762
references: ACS Chem Neurosci. 2010 Jan 20;1(1):74-83
references: 20352129
references: J Neurobiol. 2002 Feb 15;50(3):245-61
references: 11810639
references: Brain Res. 1985 Aug 19;341(1):92-100
references: 4041791
references: Cell Tissue Res. 1992 Jan;267(1):147-67
references: 1346506
references: Science. 1987 Sep 4;237(4819):1219-23
references: 2820058
references: Nature. 1997 Apr 24;386(6627):827-30
references: 9126740
references: Anal Chem. 2009 Mar 1;81(5):1848-54
references: 19192966
references: Pharmacol Rev. 1989 Mar;41(1):3-52
references: 2682679
references: PLoS One. 2008 Jan 02;3(1):e1391
references: 18167550
references: Trends Neurosci. 1991 Jul;14(7):299-302
references: 1719677
references: NIDA Res Monogr. 1992;120:13-25
references: 1501682
references: J Neurochem. 1995 Dec;65(6):2603-11
references: 7595557
references: Eur Neuropsychopharmacol. 2002 Dec;12(6):557-66
references: 12468018
references: J Pharmacol Exp Ther. 1999 Apr;289(1):266-77
references: 10087014
references: Pharmacol Biochem Behav. 2001 Mar;68(3):611-27
references: 11325419
references: Synapse. 1989;4(4):371-7
references: 2557686
references: Arch Gen Psychiatry. 1995 Jun;52(6):456-63
references: 7771915
references: Dev Biol. 2006 Aug 1;296(1):150-63
references: 16730347
references: Drugs. 1996 May;51(5):750-9
references: 8861545
references: J Pharmacol Exp Ther. 1983 Aug;226(2):382-6
references: 6410043
references: Nat Neurosci. 1998 Jun;1(2):132-7
references: 10195128
references: Trends Analyt Chem. 2009 Dec 1;28(11):1223-1234
references: 20161412
references: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704
references: 9636213
references: Nat Neurosci. 2000 May;3(5):465-71
references: 10769386
references: Neuroscience. 1988 May;25(2):513-23
references: 3399057